Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -19.49 | N/A |
| PEG Ratio (TTM) | 0.12 | N/A |
| P/S Ratio (TTM) | 0.94 | N/A |
| P/B Ratio (TTM) | 0.95 | N/A |
| P/FCF Ratio (TTM) | -5.99 | N/A |
| Price to 5YR AVG Earnings Ratio | -13.16 | N/A |
| Price to 5YR AVG FCF Ratio | -21.21 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -4.32% | N/A |
| ROE (TTM) | -4.69% | N/A |
| Net Profit Margin (TTM) | -4.85% | N/A |
| ROIC 5YR AVG | -6.48% | N/A |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -106.50% | -4,323.03% | -2,594.00% |
| Revenue | 15.69% | -2.08% | 8.43% |
| Net Income | -104.38% | -4,371.70% | -2,623.12% |
| Cash Flow | -113.27% | 14.15% | 27.82% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.20 | N/A |
| Quick Ratio (TTM) | 3.67 | N/A |
| D/E Ratio (TTM) | 0.00 | N/A |
| Interest Coverage (TTM) | 38.06 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 6.18 | N/A |
| LTL to 5YR AVG FCF | -0.06 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.35% | N/A |